[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"biomarker:mycn-gene":3},{"name":4,"total":5,"recruiting":5,"trials":6},"MYCN Gene",10,[7,15,21,27,34,40,46,52,58,64],{"nct_id":8,"title":9,"phases":10,"status":12,"updated_at":13,"content_modified":14},"NCT06057948","A Study of a Vaccine in Combination With Beta-glucan in People With Neuroblastoma",[11],"Phase 2","RECRUITING","2026-08-26T02:18:42.501841Z","2026-07-30T01:46:14.460692Z",{"nct_id":16,"title":17,"phases":18,"status":12,"updated_at":19,"content_modified":20},"NCT05489887","Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma",[11],"2026-08-26T02:19:16.454910Z","2026-07-05T05:32:16.806484Z",{"nct_id":22,"title":23,"phases":24,"status":12,"updated_at":25,"content_modified":26},"NCT02559778","Pediatric Precision Laboratory Advanced Neuroblastoma Therapy",[11],"2026-08-26T02:16:24.970704Z","2026-05-05T02:43:29.219995Z",{"nct_id":28,"title":29,"phases":30,"status":12,"updated_at":32,"content_modified":33},"NCT03126916","Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)",[31],"Phase 3","2026-08-26T02:16:49.565137Z","2026-05-05T02:43:28.673665Z",{"nct_id":35,"title":36,"phases":37,"status":12,"updated_at":38,"content_modified":39},"NCT06172296","Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma",[31],"2026-08-26T02:15:02.712396Z","2026-05-05T02:43:27.977971Z",{"nct_id":41,"title":42,"phases":43,"status":12,"updated_at":44,"content_modified":45},"NCT06528496","N10: A Study of Reduced Chemotherapy and Monoclonal Antibody (mAb)-Based Therapy in Children With Neuroblastoma",[11],"2026-08-26T02:16:55.892527Z","2026-05-05T02:43:27.797534Z",{"nct_id":47,"title":48,"phases":49,"status":12,"updated_at":50,"content_modified":51},"NCT05382338","A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss",[31],"2026-08-26T02:16:59.895916Z","2026-05-05T02:43:27.063287Z",{"nct_id":53,"title":54,"phases":55,"status":12,"updated_at":56,"content_modified":57},"NCT04936529","A Study of a Vaccine in Combination With β-glucan and GM-CSF in People With Neuroblastoma",[11],"2026-08-26T02:19:06.150683Z","2026-05-05T02:43:26.905340Z",{"nct_id":59,"title":60,"phases":61,"status":12,"updated_at":62,"content_modified":63},"NCT06540963","Tipifarnib and Naxitamab for Relapsed\u002FRefractory Neuroblastoma",[11],"2026-08-26T02:18:08.005333Z","2026-05-05T02:43:26.769225Z",{"nct_id":65,"title":66,"phases":67,"status":12,"updated_at":69,"content_modified":70},"NCT06161519","PLX038 in Primary Central Nervous System Tumors Containing MYC or MYCN Amplifications",[68],"Phase 1\u002FPhase 2","2026-08-26T02:16:39.977107Z","2026-05-05T02:43:28.398018Z"]